UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

OX40: Structure and function – What questions remain?

Molecular immunology, 2017-03, Vol.83, p.13-22

2017

Volltextzugriff (PDF)

Coupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain

Cell reports (Cambridge), 2017-01, Vol.18 (2), p.391-405

2017

Volltextzugriff (PDF)

Fc-Engineering for Modulated Effector Functions-Improving Antibodies for Cancer Treatment

Antibodies (Basel), 2020-11, Vol.9 (4), p.64

2020

Volltextzugriff (PDF)

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Frontiers in immunology, 2017-10, Vol.8, p.1245-1245

2017

Volltextzugriff (PDF)

Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives

Frontiers in immunology, 2023-04, Vol.14, p.1147467

2023

Volltextzugriff (PDF)

Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies

Cancer cell, 2015-01, Vol.27 (1), p.138-148

2015

Volltextzugriff (PDF)

Mechanisms of killing by anti-CD20 monoclonal antibodies

Molecular immunology, 2007-09, Vol.44 (16), p.3823-3837

2007

Volltextzugriff (PDF)

Activation of GABA(A) receptors inhibits T cell proliferation

PloS one, 2021-05, Vol.16 (5), p.e0251632-e0251632

2021

Volltextzugriff (PDF)

Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics

Nature reviews. Cancer, 2009-05, Vol.9 (5), p.321-326

2009

Volltextzugriff (PDF)

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2015-05, Vol.67 (8), p.2046-2055

2015

Volltextzugriff (PDF)

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Blood, 2011-04, Vol.117 (17), p.4519-4529

2011

Volltextzugriff (PDF)

Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2017-06, Vol.31 (3), p.151-166

2017

Volltextzugriff (PDF)

Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics

PLoS medicine, 2007-10, Vol.4 (10), p.1681-89; discussion 1690

2007

Volltextzugriff (PDF)

IL-4 enhances expression and function of surface IgM in CLL cells

Blood, 2016-06, Vol.127 (24), p.3015-3025

2016

Volltextzugriff (PDF)

Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation

Molecular & cellular proteomics, 2018-04, Vol.17 (4), p.776-791

2018

Volltextzugriff (PDF)

IgG subclasses determine pathways of anaphylaxis in mice

Journal of allergy and clinical immunology, 2017-01, Vol.139 (1), p.269-280.e7

2017

Volltextzugriff (PDF)

Human leukocyte immunoglobulin-like receptors in health and disease

Frontiers in immunology, 2023, Vol.14, p.1282874

2023

Volltextzugriff (PDF)

Immune characterization of pre-clinical murine models of neuroblastoma

Scientific reports, 2020-10, Vol.10 (1), p.16695-17, Article 16695

2020

Volltextzugriff (PDF)

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

Blood, 2012-04, Vol.119 (15), p.3523-3533

2012

Volltextzugriff (PDF)

Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy

Nature immunology, 2023-08, Vol.24 (8), p.1244-1255

2023

Volltextzugriff (PDF)

Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy

Blood, 2011-09, Vol.118 (9), p.2530-2540

2011

Volltextzugriff (PDF)

Anti-CD20 monoclonal antibodies: historical and future perspectives

Haematologica (Roma), 2010-01, Vol.95 (1), p.135-143

2010

Volltextzugriff (PDF)

Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy

Frontiers in immunology, 2021-02, Vol.11, p.605231-605231

2021

Volltextzugriff (PDF)

Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies

Cancers, 2021-09, Vol.13 (19), p.4904

2021

Volltextzugriff (PDF)

1 – 25 von 313

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(291)
Mit Volltextzugriff
(277)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(312)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(200)
Life Sciences & Biomedicine
(183)
Humans
(151)
Animals
(93)
Immunology
(64)
Mice
(64)
Immunotherapy
(56)
Oncology
(44)
Cancer
(40)
Hematology
(38)
Antibodies, Monoclonal - Immunology
(33)
Rituximab
(32)
Cell Biology
(29)
Female
(29)
Antibodies, Monoclonal - Therapeutic Use
(27)
Monoclonal Antibodies
(27)
Antibodies, Monoclonal - Pharmacology
(26)
Cell Line, Tumor
(26)
Tumors
(24)
Biological And Medical Sciences
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

OX40: Structure and function – What questions remain?

Coupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain

Fc-Engineering for Modulated Effector Functions-Improving Antibodies for Cancer Treatment

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives

Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies

Mechanisms of killing by anti-CD20 monoclonal antibodies

Activation of GABA(A) receptors inhibits T cell proliferation

Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering

Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics

IL-4 enhances expression and function of surface IgM in CLL cells

Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation

IgG subclasses determine pathways of anaphylaxis in mice

Human leukocyte immunoglobulin-like receptors in health and disease

Immune characterization of pre-clinical murine models of neuroblastoma

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy

Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy

Anti-CD20 monoclonal antibodies: historical and future perspectives

Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo

Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy

Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies

Suchergebnisse filtern